YIELD10 Bioscience, Inc.
YTENDelisted Jul 19, 2024- Industry
- Agricultural Production-Crops
- SEC CIK
- 0001121702
YIELD10 Bioscience, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Aug 20, 2024; 20 institutions reported holding it in 13F filings for Q1 2024, worth $612.1K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in YIELD10 Bioscience, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
YTEN is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 0
- −20 vs. Q1 2024
- Shares held
- 0
- −1.59M (−100.0%) vs. Q1 2024
- Total value
- $0
- −$612.1K (−100.0%) vs. Q1 2024
- New holders
- 0
- 0 more added
- Sold out
- 20
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YTEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 20 | $612.1K |
| Q4 2023 | 18 | $144.6K |
| Q3 2023 | 18 | $206.5K |
| Q2 2023 | 14 | $1.51M |
| Q1 2023 | 13 | $1.34M |
| Q4 2022 | 16 | $797.0K |
| Q3 2022 | 14 | $1.19M |
| Q2 2022 | 15 | $1.01M |
| Q1 2022 | 17 | $4.35M |
| Q4 2021 | 16 | $4.28M |
| Q3 2021 | 16 | $5.66M |
| Q2 2021 | 21 | $9.12M |
| Q1 2021 | 23 | $15.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding YIELD10 Bioscience, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 0 | $0 | 0.00% | −925,860−100.0% | Sold out |
| Spears Abacus Advisors LLC | 0 | $0 | 0.00% | −248,113−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −78,385−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −62,497−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −51,217−100.0% | Sold out |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −40,451−100.0% | Sold out |
| Grand Wealth Management, LLC | 0 | $0 | 0.00% | −12,159−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −31,373−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −19,134−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −18,750−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,336−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,357−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,661−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,255−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Vima LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |